QuidelOrtho Corporation (QDEL)

NASDAQ

$29.07

+$0.27 (0.94%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$28.21$29.42

Open $28.99

52 Week Range

$19.50$49.45

Previous Close $28.80

Market Cap1.97B

Volume895.65K

Avg Volume1.41M

P/E (TTM)-1.68

EPS (TTM)$-17.35

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for QuidelOrtho Corporation

NOV242025

QuidelOrtho To Participate In Upcoming Investor Conferences

Source: PRNewsWire•21 days ago

SAN DIEGO , Nov. 24, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, announced today that members of its management team will participate in two upcoming investor conferences: Ever...

NOV202025

The Power of Prevention: Detecting Diabetes Before It Strikes

Source: PRNewsWire•25 days ago

SAN DIEGO , Nov. 20, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 53 of its Science Bytes podcast, featuring Qian Ding, MD, PhD, Senior Medical Affairs Manager, QuidelOrtho...

NOV52025

QuidelOrtho Reports Third Quarter 2025 Financial Results

Source: PRNewsWire•40 days ago

― Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ― ― Successful completion of debt refinancing, enhancing financial flexibility through improv...

NOV32025

QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

Source: PRNewsWire•42 days ago

Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction SAN DIEGO , Nov. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted QuidelOrtho Corporation (Na...

OCT232025

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

Source: PRNewsWire•53 days ago

SAN DIEGO , Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George Wierschem, MBA, MT(ASCP), Senior Global Product Manager ...

OCT222025

QuidelOrtho to Report Third Quarter 2025 Financial Results

Source: PRNewsWire•54 days ago

SAN DIEGO , Oct. 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report its financial results for the third quarter 2025 ended Sep...

OCT162025

QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025

Source: PRNewsWire•60 days ago

FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine SAN DIEGO , Oct. 16, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnost...

SEP252025

Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters

Source: PRNewsWire•81 days ago

SAN DIEGO , Sept. 25, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released the latest episode of its Science Bytes podcast, featuring Dr. Terry O'Neil, President and Medical Director of Ur...

SEP222025

QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use

Source: PRNewsWire•84 days ago

SAN DIEGO , Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of innovative in vitro diagnostic technologies, is expanding ...